Beirne Wealth Consulting Services, LLC Bristol Myers Squibb CO Transaction History

Beirne Wealth Consulting Services, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$59.34 - $66.74 $326,488 - $367,203	-5,502 Closed	0 $0
Q4 2020 Feb 03, 2021	BUY	$57.74 - $65.43 $346 - $392	6 Added 0.11%	5,502 $344,000
Q3 2020 Nov 05, 2020	BUY	$57.43 - $63.64 $315,635 - $349,765	5,496 New	5,496 $331,000
Q1 2019 May 14, 2019	SELL	$45.12 - $53.8 $196,136 - $233,868	-4,347 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$48.76 - $63.23 $211,959 - $274,860	4,347 New	4,347 $226,000

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Beirne Wealth Consulting Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Beirne Wealth Consulting Services, LLC with notifications on news.